Genkyotex

Small molecule therapeutics that selectively inhibit NOX enzymes

placeGeneva, Geneva, Switzerland calendar_todayFounded 2006 groups11 employees language genkyotex.com

Innovation

6 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 70 times.

YearFilings
20161
20171
20183
20193
20201
20232

Investor mix

15 investors on record.

Investor typeCountShare
Venture capital747%
Private equity213%
Accelerator & incubator17%
Bank & private debt213%
Other / undisclosed320%
Coming soon